Literature DB >> 26706614

The negative impact of antibiotic resistance.

N D Friedman1, E Temkin2, Y Carmeli3.   

Abstract

Antibacterial therapy is one of the most important medical developments of the twentieth century; however, the spread of resistance in healthcare settings and in the community threatens the enormous gains made by the availability of antibiotic therapy. Infections caused by resistant bacteria lead to up to two-fold higher rates of adverse outcomes compared with similar infections caused by susceptible strains. These adverse outcomes may be clinical or economic and reflect primarily the failure or delay of antibiotic treatment. The magnitude of these adverse outcomes will be more pronounced as disease severity, strain virulence, or host vulnerability increases. The negative impacts of antibacterial resistance can be measured at the patient level by increased morbidity and mortality, at the healthcare level by increased resource utilization, higher costs and reduced hospital activity and at the society level by antibiotic treatment guidelines favouring increasingly broad-spectrum empiric therapy. In this review we will discuss the negative impact of antibiotic resistance on patients, the healthcare system and society.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic; antimicrobial; infection; resistance; selective pressure

Mesh:

Substances:

Year:  2015        PMID: 26706614     DOI: 10.1016/j.cmi.2015.12.002

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  133 in total

1.  Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.

Authors:  Michael A Pfaller; Michael D Huband; Dee Shortridge; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

Review 2.  The role of micropeptides in biology.

Authors:  Rui Vitorino; Sofia Guedes; Francisco Amado; Manuel Santos; Nobuyoshi Akimitsu
Journal:  Cell Mol Life Sci       Date:  2021-01-28       Impact factor: 9.261

Review 3.  Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges.

Authors:  Parteek Prasher; Manjeet Singh; Harish Mudila
Journal:  3 Biotech       Date:  2018-09-14       Impact factor: 2.406

Review 4.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

5.  Conjugative transmission of antibiotic-resistance from stream water Escherichia coli as related to number of sulfamethoxazole but not class 1 and 2 integrase genes.

Authors:  Suhartono Suhartono; Mary Savin
Journal:  Mob Genet Elements       Date:  2016-11-04

6.  The IOU Consensus Recommendations for Empirical Therapy of Cystitis in Nursing Home Residents.

Authors:  Joseph T Hanlon; Subashan Perera; Paul J Drinka; Christopher J Crnich; Steven J Schweon; Michele Klein-Fedyshin; Charles B Wessel; Stacey Saracco; Gulsum Anderson; Mary Mulligan; David A Nace
Journal:  J Am Geriatr Soc       Date:  2018-12-24       Impact factor: 5.562

7.  Early clinical experience of bacteriophage therapy in 3 lung transplant recipients.

Authors:  Saima Aslam; Andrew M Courtwright; Christine Koval; Susan M Lehman; Sandra Morales; Carrie-Lynn Langlais Furr; Francisco Rosas; Michael J Brownstein; Joseph R Fackler; Brittany M Sisson; Biswajit Biswas; Matthew Henry; Truong Luu; Brittany N Bivens; Theron Hamilton; Christopher Duplessis; Cathy Logan; Nancy Law; Gordon Yung; Jason Turowski; Judith Anesi; Steffanie A Strathdee; Robert T Schooley
Journal:  Am J Transplant       Date:  2019-07-17       Impact factor: 8.086

8.  Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.

Authors:  Joyce Wang; Betsy Foxman; Lona Mody; Evan S Snitkin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

9.  Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.

Authors:  Sameer S Kadri; Jeffrey R Strich; Bruce J Swihart; Samuel Hohmann; John P Dekker; Tara Palmore; Stephanie Bonne; Bradley Freeman; Jillian Raybould; Nirav G Shah; Devang Patel; Jennifer Husson; Mitchell D Jacobs; Lan Duong; Dean Follmann; David C Hooper; Joseph Timpone; Robert L Danner
Journal:  Am J Infect Control       Date:  2019-02-27       Impact factor: 2.918

10.  Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.

Authors:  Bingyun Li; Thomas J Webster
Journal:  J Orthop Res       Date:  2017-08-11       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.